Conceptus(R) Reports First Quarter Financial Results
29 avr. 2013 02h35 HE
|
Conceptus, Inc.
Worldwide sales of $34.1 million reflects growth of 17.5%
U.S. Essure® sales grow 22.2%
Adjusted EBITDA reaches $7.7 million
MOUNTAIN VIEW, Calif., April 29, 2013 (GLOBE...
Bayer HealthCare to Acquire Conceptus(R)
29 avr. 2013 02h30 HE
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif. and LEVERKUSEN, Germany, April 29, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth...
Conceptus(R) to Hold First Quarter Financial Results Conference Call on April 30, 2013
09 avr. 2013 16h05 HE
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., April 9, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading non-surgical permanent birth control method, today...
Conceptus(R) to Participate in the 25th Annual ROTH Investment Conference
27 févr. 2013 16h05 HE
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced...
Conceptus(R) Announces Enrollment of First Patient in European Clinical Trial for Next Generation Essure(R)
05 févr. 2013 16h08 HE
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced today...
Conceptus(R) Reports Fourth Quarter Financial Results and Introduces 2013 Financial Guidance
05 févr. 2013 16h05 HE
|
Conceptus, Inc.
New ACOG Practice Bulletin Highlights Hysteroscopic Sterilization for the First Time
Record sales of $40.7 million reflects growth of 21.5%; 23.6% constant currency Essure only
Record U.S....
Conceptus(R) Names Joseph G. Sharpe as Executive Vice President of Operations
22 janv. 2013 07h30 HE
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Jan. 22, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced...
Conceptus(R) to Hold Fourth Quarter Financial Results Conference Call on February 5, 2013
08 janv. 2013 07h30 HE
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Jan. 8, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading non-surgical permanent birth control method, today announced...
Conceptus(R) to Present at the J.P. Morgan 31st Annual Healthcare Conference
26 déc. 2012 15h00 HE
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Dec. 26, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced...
CORRECTING AND REPLACING -- Conceptus(R) Praises France's UNCAM Decision to Remove Age Restrictions on Reimbursement for Essure(R) Permanent Birth Control
14 nov. 2012 10h12 HE
|
Conceptus, Inc.
MOUNTAIN VIEW, Calif., Nov. 14, 2012 (GLOBE NEWSWIRE) -- In a release issued earlier today by Conceptus, Inc. (Nasdaq:CPTS), the date for the UNCAM decision to be effective was incorrect in the...